API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.globenewswire.com/news-release/2024/03/18/2848135/0/en/Inventiva-announces-positive-results-from-the-Phase-II-LEGEND-Proof-of-Concept-study-combining-lanifibranor-with-empagliflozin-in-patients-with-MASH-NASH-and-T2D.html
https://www.globenewswire.com//news-release/2024/03/13/2845818/0/en/Inventiva-to-present-the-results-of-LEGEND-Phase-IIa-combination-trial-with-lanifibranor-and-empagliflozin-in-patients-with-MASH-NASH-and-T2D.html
https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/boehringers-jardiance-now-gets-cdsco-nod-for-chronic-kidney-disease/articleshow/107699891.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://www.boehringer-ingelheim.com/promising-phase-ii-results-chronic-kidney-disease
https://endpts.com/boehringer-agrees-to-comply-with-cms-price-negotiations-over-blockbuster-jardiance/
https://www.prnewswire.com/news-releases/us-fda-approves-jardiance-for-the-treatment-of-adults-with-chronic-kidney-disease-301936176.html
https://www.reuters.com/business/healthcare-pharmaceuticals/us-name-first-10-drugs-medicare-price-negotiation-2023-08-29/
https://pharmaphorum.com/news/jardiance-cleared-eu-ckd-challenging-forxiga
https://www.businesswire.com/news/home/20230623740785/en/Jardiance%C2%AE-recommended-for-the-treatment-of-adults-with-chronic-kidney-disease-in-the-EU
https://www.pharmaceutical-technology.com/news/fda-grants-access-to-new-class-of-paediatric-diabetes-medicine/
https://www.prnewswire.com/news-releases/fda-approves-new-class-of-medicines-to-treat-pediatric-type-2-diabetes-301855985.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212339
https://www.reuters.com/business/healthcare-pharmaceuticals/boehringers-profit-up-14-jardiance-gains-offset-impairments-2023-03-29/
https://www.fiercepharma.com/pharma/boehringer-ingelheim-and-eli-lillys-jardiance-get-big-lift-heart-failure-indications
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-29-2023-93363.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212343
https://www.pharmatimes.com/news/nice_fails_to_recommend_boehringer_ingelheim_and_lilly_alliances_empagliflozin_1486404
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212362
https://www.pharmaceutical-technology.com/news/fda-lilly-boehringer-ingelheim-jardiance/
https://www.prnewswire.com/news-releases/us-fda-accepts-supplemental-new-drug-application-for-jardiance-for-adults-with-chronic-kidney-disease-301726873.html
https://www.indianpharmapost.com/news/torrent-enters-into-co-marketing-partnership-with-boehringer-ingelheim-india-13452
https://www.fiercepharma.com/pharma/eli-lilly-committed-gip-class-expects-over-30-billion-2023-revenues-4-new-product-launches
https://www.europeanpharmaceuticalreview.com/news/177204/jardiance-improves-blood-sugar-control-in-type-2-diabetes/
https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-boehringer-say-jardiance-slows-kidney-disease-progression-trial-2022-11-04/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212382
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212366
https://endpts.com/sales-of-boehringer-ingelheims-diabetes-pulmonary-drugs-jump-amid-11b-in-first-half-total/
https://www.expresspharma.in/zydus-gets-final-us-fda-approval-for-empagliflozin-tablets/
https://health.economictimes.indiatimes.com/news/pharma/zydus-receives-final-approval-from-usfda-for-type-2-diabetes-tablets/93344737
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212138
https://health.economictimes.indiatimes.com/news/pharma/zydus-receives-final-fda-approval-for-type-2-diabetes-drug/92797033
https://www.globenewswire.com/news-release/2022/07/07/2476242/0/en/Inventiva-announces-the-screening-of-the-first-patient-in-LEGEND-a-Phase-IIa-combination-trial-with-lanifibranor-and-empagliflozin-in-patients-with-NASH-and-T2D.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212198
https://www.fiercepharma.com/marketing/lilly-and-boehringers-jardiance-poised-battle-azs-farxiga-chronic-kidney-disease-spherix
https://www.prnewswire.com/news-releases/jardiance-decreased-relative-risk-of-hospitalization-for-heart-failure-by-50-versus-dpp-4-inhibitors-and-by-30-versus-glp-1-receptor-agonists-in-adults-with-type-2-diabetes-in-real-world-evidence-study-301561303.html
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/boehringer-ingelheim-gets-cdsco-nod-for-jardiance-to-treat-for-new-heart-failure-indication/articleshow/91671152.cms
https://endpts.com/eli-lilly-and-boehringer-ingelheim-urge-women-to-become-their-own-heart-health-advocates-in-new-campaign/
https://www.fiercepharma.com/asia/jardiance-sparks-boehringer-ingelheims-2021-sales-potential-much-more-growth-2022
https://www.reuters.com/business/healthcare-pharmaceuticals/boehringers-operating-income-edges-up-jardiance-animal-health-2022-04-05/
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/himachal-pradesh-high-court-stays-drl-from-selling-bis-diabetic-drug-jardiance/articleshow/90575276.cms
https://www.prnewswire.com/news-releases/jardiance-phase-iii-empa-kidney-trial-will-stop-early-due-to-clear-positive-efficacy-in-people-with-chronic-kidney-disease-301504008.html
https://www.fiercepharma.com/pharma/eli-lilly-boehringer-ingelheims-jardiance-widens-heart-failure-foothold-eu-approval-turning
https://www.europeanpharmaceuticalreview.com/news/169008/empagliflozin-benefit-adults-hospitalised-acute-heart-failure/
https://www.prnewswire.com/news-releases/jardiance-provided-a-significant-clinical-benefit-in-adults-stabilized-in-hospital-following-acute-heart-failure-in-empulse-phase-iii-trial-301492927.html
https://seekingalpha.com/news/3805360-lilly-boehringer-ingelheims-jardiance-granted-expanded-indication-in-heart-failure
http://www.pharmafile.com/news/605921/nice-approves-new-treatment-chronic-heart-failure